Sort   by:  
 Page size 
ProteomicsPlasma proteomics-based biomarkers for predicting response to mesenchymal stem cell therapy in severe COVID-19
In March 2020, we performed a multicenter, randomized, double-blind phase II study of mesenchymal stem cells (MSCs) therapy in patients with severe COVID-19 (ClinicalTrials.gov: NCT04288102). Findings showed that MSC was a potentially effective therapeutic approach for patients with severe COVID-19,...
ORGANISM(S): Homo Sapiens 
2023-05-10 | PXD042106 |
ProteomicsNeutralization mechanism of a HipA-like toxin targeting isoleucyl-tRNA synthetase
HipAB is a type II toxin-antitoxin (TA) system that targets and inactivates specific aminoacyl-tRNA synthetases in response to various stresses. While the molecular targets and neutralization mechanisms of several HipAB-like TA systems have been well characterized, their structural and functional di...
ORGANISM(S): Escherichia Coli K-12 
2025-04-11 | PXD062828 |
Sort   by:  
 Page size